- Home
- BMRN vs TTEK Comparison
BMRN vs TTEK Comparison
Compare BMRN & TTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | TTEK |
|---|---|---|
| Founded | 1996 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 8.6B |
| IPO Year | 1999 | 1991 |
Fundamental Metrics
Financial Performance| Metric | BMRN | TTEK |
|---|---|---|
| Price | $55.79 | $34.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 5 |
| Target Price | ★ $90.00 | $43.25 |
| AVG Volume (30 Days) | ★ 3.1M | 3.1M |
| Earning Date | 10-27-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 0.75% |
| EPS Growth | ★ 59.53 | N/A |
| EPS | ★ 2.68 | 0.93 |
| Revenue | $3,094,001,000.00 | ★ $4,617,360,000.00 |
| Revenue This Year | $13.32 | N/A |
| Revenue Next Year | $7.51 | $6.83 |
| P/E Ratio | ★ $20.86 | $37.35 |
| Revenue Growth | ★ 12.39 | 6.84 |
| 52 Week Low | $50.76 | $27.27 |
| 52 Week High | $73.51 | $43.50 |
Technical Indicators
Market Signals| Indicator | BMRN | TTEK |
|---|---|---|
| Relative Strength Index (RSI) | 57.07 | 54.40 |
| Support Level | $54.51 | $32.43 |
| Resistance Level | $56.45 | $36.03 |
| Average True Range (ATR) | 1.53 | 1.19 |
| MACD | 0.28 | 0.06 |
| Stochastic Oscillator | 81.90 | 54.64 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About TTEK Tetra Tech Inc.
Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. it has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.